Latest news with #DoH
Arabian Business
an hour ago
- Health
- Arabian Business
DoH and Sanofi partner to develop new global vaccines in Abu Dhabi
The Department of Health – Abu Dhabi (DoH) and Sanofi, one of the world's leading biopharma companies, will team up to develop new global vaccines and strengthen regional capabilities in vaccine manufacturing. The two organisations signed a memorandum of understanding to this effect at the BIO International Convention 2025, in Boston, USA, recently. Dr Noura Khamis Al Ghaithi, Under-Secretary of the Department of Health – Abu Dhabi, and Laurie Gery, Global Head of Business Development, Vaccines at Sanofi, were present at the signing ceremony. DoH and Sanofi strengthen health collaboration The collaboration will leverage Abu Dhabi's health-tech ecosystem and advanced research infrastructure and Sanofi's research and development expertise. It reflects Abu Dhabi's goal to establish the emirate as a leading centre for bio- and pharmaceutical innovation. Both entities will collaborate to streamline regulatory processes, enhance manufacturing preparedness, and foster knowledge sharing among local and international experts. View this post on Instagram A post shared by دائرة الصحة – أبوظبي "DoH" (@dohsocial) Dr Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at the DoH, commented: 'DoH is partnering with Sanofi to expedite the development of new global vaccines. This initiative aims to shorten the timeline from early research to public availability by utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases. 'By combining Sanofi's global scientific expertise with Abu Dhabi's state-of-the-art infrastructure, we set new benchmarks for resilience, innovation and international partnerships. Abu Dhabi offers a globally connected, purpose-driven environment for leading research, and together we will drive a transformative change that will safeguard the health and well-being of our community while contributing to global health security.' Both organisations will advance clinical research and development planning, optimise resource allocation and establish the foundational terms for funding and access. DoH and Sanofi are collaborating in other areas as well. In 2022, the two parties agreed to work on four strategic healthcare priorities, including hematology and oncology, rare metabolic diseases, diabetes management and vaccines. Baptiste de Clarens, General Manager Greater Gulf, Vaccines, Sanofi, added: 'The Memorandum of Understanding signed with the Department of Health – Abu Dhabi marks an encouraging step towards advancing global health security while reflecting our shared interest in addressing global health challenges through scientific partnership. 'This agreement allows us to examine how Sanofi's experience in vaccine development could complement Abu Dhabi's growing R&D ecosystem. Through this initial framework, we look forward to exploring opportunities for public-private collaboration in healthcare innovation.'
Gulf Business
5 hours ago
- Health
- Gulf Business
Future of weight loss: Inside Abu Dhabi's latest health programme
Image credit: WAM/ Website The Department of Health – Abu Dhabi (DoH) and Abu Dhabi Public Health Centre (ADPHC) have announced the launch of a first-of-its-kind Personalised Weight Management Programme in the region. Combining digital monitoring, a unique reimbursement model, and tailored clinical support, the initiative promotes sustainable weight management and active living. It aims to significantly reduce the risk of chronic diseases such as type 2 diabetes, heart disease, and certain cancers—ultimately enhancing quality of life and health longevity. Innovative model for long-term health impact The programme is open to eligible Thiqa members aged 18 and above who are clinically identified as overweight or obese. It features an innovative reimbursement model designed to encourage sustained engagement, personal accountability, and continuous participation. Read- 'Our focus is on health—not just weight. This programme supports our vision of an active, health-conscious community by empowering individuals through personalised, science-driven solutions. Weight management requires customised approaches, not a 'one-size-fits-all' model, and this programme ensures that each participant receives the support they need to succeed,' said Dr. Noura Al Ghaithi, Undersecretary of DoH. Bridging gaps in preventive healthcare 'We know that even modest weight loss and small increases in physical activity can significantly lower the risk of chronic disease. Traditionally, healthcare systems have lacked clear pathways for doctors to support patients in becoming more physically active or in connecting them with relevant services. Our programme addresses this gap by providing structured guidance, personalised activity plans, and continuous monitoring through digital tools and clinical oversight—empowering our community to proactively manage their health and improve their quality of life,' said Dr. Rashid Obaid Al Suwaidi, Director-General of ADPHC.
Al Bawaba
5 hours ago
- Health
- Al Bawaba
The Department of Health – Abu Dhabi and Abbott Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi
Department of Health -Abu Dhabi is the regulative body of the Healthcare Sector in the Emirate of Abu Dhabi and ensures excellence in Healthcare for the community by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world – class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programs to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system in the Emirate of Abu Dhabi.
Zawya
6 hours ago
- Health
- Zawya
Abu Dhabi launches unique personalised weight management programme to reduce chronic disease
ABU DHABI - The Department of Health – Abu Dhabi (DoH) and Abu Dhabi Public Health Centre (ADPHC) announced the launch of a new, first-of-its-kind in the region, Personalised Weight Management Programme. Integrating digital monitoring, a unique reimbursement model and tailored clinical support, this initiative promotes sustainable weight management and active living to significantly reduce the risks of chronic diseases such as type 2 diabetes, heart disease, and certain cancers, and ultimately, enhancing overall quality of life and health longevity. Open to eligible Thiqa members aged 18 and above who are clinically identified as overweight or obese, the programme features an innovative reimbursement model designed to encourage sustained engagement, accountability, and continuous active participation. Dr. Noura Al Ghaithi, Undersecretary of DoH, said, 'Our focus is on health – not just weight. This programme supports our vision for an active, health-conscious community, empowering individuals through personalised and science-driven solutions. Weight management requires tailored solutions, not a 'one-size-fits-all' approach, and this programme ensures each participant receives precisely what they need to succeed.' Dr. Rashid Obaid Al Suwaidi, Director-General of ADPHC, stated, 'We know that even moderate weight loss and modest increases in physical activity significantly lower chronic disease risk. Traditionally, healthcare systems have lacked clear pathways for doctors to support patients in becoming physically active or to effectively link them with supportive services. Our programme directly addresses this gap by providing structured guidance, personalised activity plans, and continuous monitoring support through digital tools and clinical oversight - empowering our community to proactively manage their health and enhance their quality of life.'
Zawya
a day ago
- Health
- Zawya
DoH, Sanofi partner to accelerate development of new global vaccines in Abu Dhabi
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company at the BIO International Convention 2025, in Boston, USA. The collaboration will leverage the Emirate's health-tech ecosystem and advanced research infrastructure to drive the development of new global vaccines and strengthen regional capabilities in vaccine manufacturing. In the presence of Dr. Noura Khamis Al Ghaithi, Under-Secretary of the Department of Health – Abu Dhabi, and Laurie Gery, Global Head of Business Development, Vaccines at Sanofi, the agreement was signed during the BIO International Convention in Boston, USA, by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Baptiste de Clarens, General Manager Greater Gulf, Vaccines at Sanofi. Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at the DoH, said. 'DoH is partnering with Sanofi to expedite the development of new global vaccines. This initiative aims to shorten the timeline from early research to public availability by utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases. By combining Sanofi's global scientific expertise with Abu Dhabi's state-of-the-art infrastructure, we set new benchmarks for resilience, innovation and international partnerships. Abu Dhabi offers a globally connected, purpose-driven environment for leading research, and together we will drive a transformative change that will safeguard the health and well-being of our community while contributing to global health security.' Both entities will work together to streamline regulatory processes, enhance manufacturing preparedness, and promote knowledge sharing between local and international experts. This partnership reflects Abu Dhabi's strategic goal to establish itself as a leading centre for bio- and pharmaceutical innovation and underscores the emirate's commitment to advancing proactive, technology-driven healthcare solutions. Baptiste de Clarens, General Manager Greater Gulf, Vaccines, Sanofi, said, 'The Memorandum of Understanding signed with the Department of Health – Abu Dhabi marks an encouraging step towards advancing global health security while reflecting our shared interest in addressing global health challenges through scientific partnership. This agreement allows us to examine how Sanofi's experience in vaccine development could complement Abu Dhabi's growing R&D ecosystem. Through this initial framework, we look forward to exploring opportunities for public-private collaboration in healthcare innovation.' In addition, both the Department and Sanofi will advance clinical research and development planning, optimise resource allocation and establish the foundational terms for funding and access. These efforts are designed to enhance healthcare resilience and sustainability across Abu Dhabi's healthcare sector and beyond, expanding access to quality care for patients locally and globally.
